Rexer BN, Arteaga CL. Optimal tageting of HER2-PI3K signaling in breast cancer: Mechanistic insights and clinical implications. Cancer Res. 2013 Jul 1;73(13):3817-20. - Stand Up To Cancer

Blog

Posted September 17, 2019

Rexer BN, Arteaga CL. Optimal tageting of HER2-PI3K signaling in breast cancer: Mechanistic insights and clinical implications. Cancer Res. 2013 Jul 1;73(13):3817-20.

JOIN OUR COMMUNITY

Sign up to receive emails from Stand Up To Cancer.
   Please leave this field empty
Stand Up to Cancer

Thanks for signing up!
You will hear from us soon.